Drug · DIN 00324019
ANAFRANIL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since March 12, 2021; first marketed December 31, 1973.
- Drug Identification Number (DIN)
- 00324019
- Company (DIN owner)
- Apotex Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Clomipramine N06AA04
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CLOMIPRAMINE HYDROCHLORIDE | 25 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 30, 2020: NOC 24333New Drug Submission (NDS) · Change in product ownership
- August 4, 2017: NOC 19638New Drug Submission (NDS) · Administrative: Transfer of Drug Identification Numbers
- March 11, 2015: NOC 16685New Drug Submission (NDS) · Transfer of drug identification number
- June 21, 2012: NOC 13403New Drug Submission (NDS) · Manufacturer name change
- August 11, 2009: NOC 10490New Drug Submission (NDS) · Manufacturer name change
- October 15, 2002: NOC 341New Drug Submission (NDS) · Manufacturer name change
- May 15, 1997: NOC 3671New Drug Submission (NDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “anafranil”. A notice may cover another product or only some lots: read it to see what it covers.
- Anafranil 10 mg (2017-11-16)November 21, 2017 · Drugs · Product safety · Type II
Other DINs named ANAFRANIL
- DIN 00330566 · Marketed
- DIN 00402591 · Marketed